Drug class in one race
Erythropoietin receptor (EPO-R) drugs for Chronic Kidney Disease
5 tracked Erythropoietin receptor (EPO-R) drugs in the Chronic Kidney Disease race. The class explanation lives on the Erythropoietin receptor (EPO-R) page; the full indication pipeline across every mechanism is on the Chronic Kidney Disease page.
4 Phase 31 Phase 2
Head-to-head evidence: JR-131 vs NNG-DEPO · JR-131 vs Pegmolesatide (HS-20039) · JR-131 vs RD01 (PEG-EPO) · JR-131 vs rESP · NNG-DEPO vs Pegmolesatide (HS-20039) · NNG-DEPO vs RD01 (PEG-EPO)